2020
AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis
Feuerstein J, Isaacs K, Schneider Y, Siddique S, Falck-Ytter Y, Singh S, Chachu K, Day L, Lebwohl B, Muniraj T, Patel A, Peery A, Shah R, Sultan S, Singh H, Singh S, Spechler S, Su G, Thrift A, Weiss J, Weizman A, Feuerstein J, Singh S, Isaacs K, Schneider Y, Falck-Ytter Y, Siddique S, Allegretti J, Terdiman J, Singh S, Siddique S. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology 2020, 158: 1450-1461. PMID: 31945371, PMCID: PMC7175923, DOI: 10.1053/j.gastro.2020.01.006.Peer-Reviewed Original ResearchAdultBiological ProductsClinical Decision-MakingClinical Trials as TopicColectomyColitis, UlcerativeColonColonoscopyDrug Therapy, CombinationEvidence-Based MedicineGastroenterologyGlucocorticoidsHumansImmunologic FactorsIntestinal MucosaSeverity of Illness IndexSocieties, MedicalTreatment OutcomeUnited States
2012
Diabetes and pancreatic cancer.
Muniraj T, Chari ST. Diabetes and pancreatic cancer. Minerva Gastroenterology 2012, 58: 331-45. PMID: 23207610, PMCID: PMC3932318.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsBody Mass IndexClinical Trials as TopicDiabetes Mellitus, Type 2Early Detection of CancerEvidence-Based MedicineGlobal HealthGlucose IntoleranceHumansHyperinsulinismHypoglycemic AgentsInsulin GlargineInsulin, Long-ActingMeta-Analysis as TopicMetforminObesityPancreatic NeoplasmsPrevalenceRisk AssessmentRisk FactorsConceptsType 2 diabetesNew-onset diabetesPancreatic cancerPancreatic cancer-associated diabetesAnti-diabetic medicationsDuration of diseasePancreatic cancer patientsYears of ageGlucose toleranceCancer patientsOnset diabetesHigh riskEpidemiological studiesDiabetesCancerAdditional markersModest increaseRiskInverse relationshipRecent studiesMedicationsPatientsDisease